With the former concentrating on cognitive deficits and the latter on anxiety and depression, both studies outline the neuroprotective benefits of isorhamnetin, which are fueled by its modulation of the oxidative stress–inflammation–BDNF axis [141,142]. This evidence concerns the gene BDNF and depressive disorder.